Plain-English translation of NCT06897475 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Type 2 Diabetes research guide →Phase 2 — Testing in a bigger group (up to a few hundred people) to see if the treatment actually works and is still safe.
This trial is testing a new medication called to see if it can help lower blood sugar levels in people with type 2 diabetes who aren't reaching their target blood sugar goals despite taking semaglutide or tirzepatide. You would receive the medication as a weekly injection under the skin. The study will compare the medication to a placebo (a dummy injection with no active medicine) to see which works better.
Some people with type 2 diabetes don't reach their blood sugar targets even with current medications like semaglutide or tirzepatide. This trial is exploring whether adding this new treatment could help those people get their blood sugar under better control.
You likely qualify if…
You likely don't qualify if…
You would participate in the study for about 9 months. During this time, you would receive weekly injections of either the new medication or a placebo under your skin. You would continue taking your current diabetes medications (semaglutide or tirzepatide) as usual. You would have regular visits to the clinic where your blood sugar levels would be checked and monitored to see how well the treatment is working.
AI-generated summary from trial data · Jun 1, 2026 · Not medical advice
United States